Electroconvulsive Therapy: A Safer Alternative to Treating Women with Major Depressive Disorder During Pregnancy

Simple item page
dc.contributorPhan, Kelle Huong
dc.contributorEdwards-Maddox, Shermel
dc.contributor.authorGonzalez, Emmanuel
dc.contributor.authorNguyen, Matthew
dc.contributor.authorSarabia, Julia
dc.date.accessioned2022-08-01T21:19:26Z
dc.date.available2022-08-01T21:19:26Z
dc.date.issued2022-08
dc.description.abstractThe common treatment for severe depression in pregnant women is selective serotonin reuptake inhibitors (SSRIs), which are assumed to be effective and harmless to the fetus; however those benefits have not been established. Studies have shown that SSRI use during pregnancy actually pose higher complications for the mother postpartum and the fetus during developmental stages. SSRIs can affect brain development in the fetus due to altered levels of serotonin during developmental sensitive periods. A more effective and safer intervention to overcoming this issue is shown with electroconvulsive therapy (ECT).en_US
dc.description.departmentNursing, College ofen_US
dc.identifier.orcid0000-0003-1622-5864en_US
dc.identifier.urihttps://hdl.handle.net/10657/10698
dc.language.isoen_USen_US
dc.subjectElectroconvulsive therapyen_US
dc.subjectMajor depressive disorderen_US
dc.subjectPregnant womenen_US
dc.subjectPregnancyen_US
dc.titleElectroconvulsive Therapy: A Safer Alternative to Treating Women with Major Depressive Disorder During Pregnancyen_US
dc.typePosteren_US

Files

Collections

2022 Summer Evidence-Based Practice Posters – NURS 3337